GSK scientists indicted for trade secret theft


Two scientists working at GlaxoSmithKline (GSK) in Pennsylvania, US, have been indicted for conspiracy to commit fraud and allegedly stealing confidential information related to its biopharmaceutical products. The indictment names five people, including scientists Yu Xue and Lucy Xi. If convicted of all charges, each defendant faces a range of punishments, including fines and possible prison terms.

The indictment claims that Xue and Xi used e-mail and USB drives to transmit information about GSK’s procedures for researching, developing, and manufacturing biopharmaceutical products designed to treat cancer or other diseases. Xue and two of the other defendants had formed a company in China called Renopharma in July 2012, allegedly to market and sell the stolen trade secret information.


Related Content

Alnylam accuses Dicerna of stealing trade secrets

19 June 2015 Business

news image

Firm claims rights to GalNAc conjugated siRNA technology acquired from Merck & Co

Suspect suicide won’t end trade secret theft probe

11 June 2015 Business

news image

An ex-PPG chemist who was arrested for selling trade secrets to a Chinese firm has killed himself, but the Justice Department...

Most Commented

New antibiotic picked from nose bacteria

27 July 2016 Research

news image

Discovery suggests human microbiome may be an untapped source of antimicrobial compounds

Perovskite boosts silicon solar cell efficiency

25 November 2015 News and Analysis

news image

Silicon industry will be ‘beating a path to the door’ of inventors, says scientist